Regeneron Pharmaceuticals Statistics
Total Valuation
REGN has a market cap or net worth of $115.26 billion. The enterprise value is $107.44 billion.
| Market Cap | 115.26B |
| Enterprise Value | 107.44B |
Important Dates
The next confirmed earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
REGN has 108.37 million shares outstanding. The number of shares has increased by 0.96% in one year.
| Shares Outstanding | 108.37M |
| Shares Change (YoY) | +0.96% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | 1.56% |
| Owned by Institutions (%) | 89.91% |
| Float | 103.39M |
Valuation Ratios
The trailing PE ratio is 31.41 and the forward PE ratio is 22.87. REGN's PEG ratio is 1.46.
| PE Ratio | 31.41 |
| Forward PE | 22.87 |
| PS Ratio | 8.80 |
| Forward PS | 8.00 |
| PB Ratio | 4.27 |
| P/FCF Ratio | 28.36 |
| PEG Ratio | 1.46 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.62, with an EV/FCF ratio of 26.43.
| EV / Earnings | 27.85 |
| EV / Sales | 8.20 |
| EV / EBITDA | 23.62 |
| EV / EBIT | 26.12 |
| EV / FCF | 26.43 |
Financial Position
The company has a current ratio of 5.27, with a Debt / Equity ratio of 0.10.
| Current Ratio | 5.27 |
| Quick Ratio | 4.40 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.59 |
| Debt / FCF | 0.67 |
| Interest Coverage | 57.85 |
Financial Efficiency
Return on equity (ROE) is 15.10% and return on invested capital (ROIC) is 12.38%.
| Return on Equity (ROE) | 15.10% |
| Return on Assets (ROA) | 11.80% |
| Return on Capital (ROIC) | 12.38% |
| Revenue Per Employee | $973,985 |
| Profits Per Employee | $286,825 |
| Employee Count | 13,450 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 0.70 |
Taxes
In the past 12 months, REGN has paid $184.20 million in taxes.
| Income Tax | 184.20M |
| Effective Tax Rate | 4.56% |
Stock Price Statistics
The stock price has increased by +47.93% in the last 52 weeks. The beta is 0.13, so REGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +47.93% |
| 50-Day Moving Average | 1,022.06 |
| 200-Day Moving Average | 925.25 |
| Relative Strength Index (RSI) | 54.11 |
| Average Volume (20 Days) | 475,374 |
Short Selling Information
The latest short interest is 2.04 million, so 1.88% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 1.85M |
| Short % of Shares Out | 1.88% |
| Short % of Float | 1.97% |
| Short Ratio (days to cover) | 4.16 |
Income Statement
In the last 12 months, REGN had revenue of $13.10 billion and earned $3.86 billion in profits. Earnings per share was $33.86.
| Revenue | 13.10B |
| Gross Profit | 11.31B |
| Operating Income | 3.85B |
| Pretax Income | 4.04B |
| Net Income | 3.86B |
| EBITDA | 4.55B |
| EBIT | 4.11B |
| Earnings Per Share (EPS) | $33.86 |
Balance Sheet
The company has $10.52 billion in cash and $2.70 billion in debt, giving a net cash position of $7.82 billion or $72.13 per share.
| Cash & Cash Equivalents | 10.52B |
| Total Debt | 2.70B |
| Net Cash | 7.82B |
| Net Cash Per Share | $72.13 |
| Equity (Book Value) | 26.99B |
| Book Value Per Share | 249.07 |
| Working Capital | 15.29B |
Cash Flow
In the last 12 months, operating cash flow was $4.74 billion and capital expenditures -$674.30 million, giving a free cash flow of $4.06 billion.
| Operating Cash Flow | 4.74B |
| Capital Expenditures | -674.30M |
| Free Cash Flow | 4.06B |
| FCF Per Share | $37.71 |
Margins
Gross margin is 86.32%, with operating and profit margins of 29.40% and 29.45%.
| Gross Margin | 86.32% |
| Operating Margin | 29.40% |
| Pretax Margin | 30.85% |
| Profit Margin | 29.45% |
| EBITDA Margin | 34.72% |
| EBIT Margin | 31.40% |
| FCF Margin | 31.03% |
Dividends & Yields
REGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.96% |
| Shareholder Yield | -0.96% |
| Earnings Yield | 3.35% |
| FCF Yield | 3.53% |
Analyst Forecast
The average price target for REGN is $1,054.67, which is -0.84% lower than the current price. The consensus rating is "Buy".
| Price Target | $1,054.67 |
| Price Target Difference | -0.84% |
| Analyst Consensus | Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (5Y) | 7.63% |
| EPS Growth Forecast (5Y) | 14.02% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
REGN has an Altman Z-Score of 11.82 and a Piotroski F-Score of 4.
| Altman Z-Score | 11.82 |
| Piotroski F-Score | 4 |